Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Rothman

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Bioorganic & Medicinal Chemistry|April 3, 2012
Semisynthetic neoclerodanes as kappa opioid receptor probesKimberly M Lovell, Tamara Vasiljevik, Juan J Araya, et al.
Plos One|November 9, 2013
Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activationTamara Antonio, Steven R Childers, Richard B Rothman, et al.
Journal of Medicinal Chemistry|December 5, 2008
Probes for narcotic receptor mediated phenomena. 37. Synthesis and opioid binding affinity of the final pair of oxide-bridged phenylmorphans, the ortho- and para-b-isomers and their N-phenethyl analogues, and the synthesis of the N-phenethyl analogues of the ortho- and para-d-isomersMuneaki Kurimura, Hehua Liu, Agnieszka Sulima, et al.
Synapse (New York, N.Y.)|December 3, 2009
Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptorElliott J Sally, Heng Xu, Christina M Dersch, et al.
Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.
Organic & Biomolecular Chemistry|April 5, 2007
Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonistsKejun Cheng, In Jong Kim, Mei-Jing Lee, et al.
Journal of Medicinal Chemistry|July 13, 2007
Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan seriesAnne-Cécile Hiebel, Yong Sok Lee, Edward Bilsky, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Bioorganic & Medicinal Chemistry|April 3, 2012
Semisynthetic neoclerodanes as kappa opioid receptor probesKimberly M Lovell, Tamara Vasiljevik, Juan J Araya, et al.
Plos One|November 9, 2013
Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activationTamara Antonio, Steven R Childers, Richard B Rothman, et al.
Journal of Medicinal Chemistry|December 5, 2008
Probes for narcotic receptor mediated phenomena. 37. Synthesis and opioid binding affinity of the final pair of oxide-bridged phenylmorphans, the ortho- and para-b-isomers and their N-phenethyl analogues, and the synthesis of the N-phenethyl analogues of the ortho- and para-d-isomersMuneaki Kurimura, Hehua Liu, Agnieszka Sulima, et al.
Synapse (New York, N.Y.)|December 3, 2009
Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptorElliott J Sally, Heng Xu, Christina M Dersch, et al.
Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.
Organic & Biomolecular Chemistry|April 5, 2007
Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonistsKejun Cheng, In Jong Kim, Mei-Jing Lee, et al.
Journal of Medicinal Chemistry|July 13, 2007
Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan seriesAnne-Cécile Hiebel, Yong Sok Lee, Edward Bilsky, et al.
Pageof 16